Pages that link to "Q37109203"

The following pages link to Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein (Q37109203):

Displaying 34 items.

• Li-fraumeni syndrome (Q22241780) (← links)
• PDBSite: a database of the 3D structure of protein functional sites (Q24796697) (← links)
• Analysis of a protein-binding domain of p53 (Q33292314) (← links)
• The role of mutant p53 in human cancer (Q34153014) (← links)
• Tumor suppressor p53 mutations and breast cancer: a critical analysis (Q34314048) (← links)
• Genetic predisposition to cancer and familial cancer syndromes (Q34438119) (← links)
• Functional studies of a germ-line polymorphism at codon 47 within the p53 gene (Q35195008) (← links)
• Cancer risks from germline p53 mutations (Q35513831) (← links)
• Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. (Q35643184) (← links)
• Using germ-line genetic variation to investigate and treat cancer (Q35829133) (← links)
• Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators (Q36081213) (← links)
• Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma (Q36135522) (← links)
• Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing (Q36159489) (← links)
• Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma (Q36202253) (← links)
• Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. (Q36287125) (← links)
• Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53 (Q36385304) (← links)
• Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression (Q36698048) (← links)
• Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent (Q36745477) (← links)
• HCV NS2 protein inhibits cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells through down-regulation of cyclin A expression (Q40312909) (← links)
• Genetics of primary brain tumors: a review (Q40686977) (← links)
• Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. (Q40792701) (← links)
• Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. (Q40817254) (← links)
• Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins (Q41027365) (← links)
• Life or death: p53-induced apoptosis requires DNA binding cooperativity. (Q42682133) (← links)
• p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome (Q48144021) (← links)
• Intracranial germ cell tumors: detection of p53 gene mutations by single-strand conformation polymorphism analysis. (Q55081375) (← links)
• Wild Type p53 Stimulates Expression from the Human Multidrug Resistance Promoter in a p53-negative Cell Line (Q56029437) (← links)
• Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations (Q64047862) (← links)
• Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer (Q71676992) (← links)
• Screening patients for heterozygous p53 mutations using a functional assay in yeast (Q72635302) (← links)
• Absence of germline and somatic p53 alterations in children with sporadic brain tumors (Q74418572) (← links)
• The Li-Fraumeni syndrome (Q77785199) (← links)
• TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies (Q89956023) (← links)
• Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses (Q93095094) (← links)